MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease在百草枯诱导的帕金森病体内模型中,MicroRNA-124-3p调节 α-突触核蛋白的表达水平NEUROCHEMICAL RESEARCHIF3.82024-03-071OAAI
Synthesis, In Vitro Biological Evaluation of Antiproliferative and Neuroprotective Effects and In Silico Studies of Novel 16E-Arylidene-5α,6α-epoxyepiandrosterone DerivativesBIOMEDICINESIF3.92023-03-071OAAI
MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson's diseaseMOLECULAR THERAPYIF122022-10-0144OAAI
New insights into the regulatory roles of microRNAs in adult neurogenesisCURRENT OPINION IN PHARMACOLOGYIF4.22020-02-0122PREAI
MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseasesBIOCHEMICAL PHARMACOLOGYIF5.62017-10-0168PREAI
Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activationJOURNAL OF NEUROINFLAMMATIONIF10.12016-06-0488OAAI
Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's diseaseFRONTIERS IN AGING NEUROSCIENCEIF4.52015-03-0681OAAI
Histamine: a new immunomodulatory player in the neuron-glia crosstalkFRONTIERS IN CELLULAR NEUROSCIENCEIF42014-04-3077OAAI